MustGrow Biologics Corp. (MGROF)

MustGrow Biologics Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-4.89	-0.68	-5.57	-3.06	-3.31
Stock-Based Compensation	1.47	0.93	1.69	0.27	0.78
Other Operating Activities	-	-	0.01	0.05	-0.06
Change in Inventory	-0.3	-	-	-	-
Change in Accounts Payable	0.52	0.1	-0.27	0.35	0.04
Change in Unearned Revenue	-0.27	-0.64	0.91	-	-
Change in Other Net Operating Assets	-0.11	-0	-0.04	-0.02	-0.03
Operating Cash Flow	-3.58	-0.29	-3.26	-2.41	-2.58
Long-Term Debt Repaid	-0.24	-	-	-	-
Net Debt Issued (Repaid)	-0.24	-	-	-	-
Issuance of Common Stock	-	0.1	0.65	8.72	1.86
Financing Cash Flow	-0.24	0.1	0.65	8.72	1.86
Net Cash Flow	-3.82	-0.2	-2.6	6.31	-0.72
Levered Free Cash Flow	-0.98	0.69	-0.99	-1.14	-1.2
Unlevered Free Cash Flow	-0.98	0.69	-0.98	-1.11	-1.17
Change in Net Working Capital	-0.37	0.54	-0.6	-0.33	-0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.